DRUG

Bright Minds Biosciences
DRUG

Overview Fund Trends Analyst Outlook Journalist POV
59.37 USD
--5.60
8.62%
At close Updated Oct 14, 10:29 AM EDT
1 day
-8.62%
5 days
15.73%
1 month
22.01%
3 months
131.46%
6 months
81.28%
Year to date
44.42%
1 year
2,284.34%
5 years
43.75%
10 years
43.75%
 

About: Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Healthcare Biotechnology
0
Funds holding %
of 7,491 funds
Explore Fund Trends
0
Analysts bullish %
of 2 analysts
See Analyst Outlook
–
Positive news %
of articles
Check Journalist POV
Price charts implemented using Lightweight Charts™